Tag: Clinical trial
Verisense Health Launched to Provide Access to a Digital Biobank of Raw Patient Data
Verisense® Health, Inc. just launched as a digital health software and data management company. It was established with the goal of providing sponsors with cost-efficient access to a digital biobank of longitudinal raw patient data. The new company is...
Sampled Leader Highlights Role of Biobanking in Addressing Historic Inequities in Healthcare
The Chief Scientific Officer at Sampled1 issued a call to action for greater diversity in clinical trial recruitment and the collection of biosamples in a letter in the current issue of Biopreservation and Biobanking. The letter by Sheldon et al,...
Utilizing Modular Biobanking Software in Different Types of Biobanking Activities
Abstract Biobanking defines all activities linked to bioresource management—whether of human, animal, microbial, or environmental origin—which means that any biobank information management system should take into account the multistep life cycle of the samples: from acquisition, through preparation, storage, to...
ATCC Awarded New Contract from the National Cancer Institute to Process Biomaterials for Cancer...
ATCC, the world’s premier biological materials management and standards organization announced that it has been selected as an awardee for the National Cancer Institute’s (NCI) Division of Cancer Epidemiology and Genetics (DCEG) Field and Biospecimen Support Services contract. Under this contract, ATCC...
Biobanking Victoria: Australia’s First Industry-Focused Flagship Biobank Launched by Monash University
Monash University has officially launched Australia’s first industry-focused storage facility for biological material to support medical research and commercialisation opportunities. Biobanking Victoria is a state-of-the-art facility that provides a valuable link between researchers and industry, generously supported by the Victorian...
Magenta Therapeutics Presented MGTA-456 At Transplant And Cellular Therapy (TCT) Annual Meeting
Magenta Therapeutics has announced that the company presented Phase 2 clinical data and preclinical research on its MGTA-456 program at the TCT annual meeting. Founded in 2015, headquartered in Cambridge, Massachusetts, USA, Magenta Therapeutics is a clinical-stage biotechnology company developing...
BrainStorm Cell Therapeutics Contracts Cleveland Clinic For Multiple Sclerosis Clinical Trial Site
BrainStorm Cell Therapeutics Inc., has announced that the Cleveland Clinic is the first U.S. clinical site contracted for a planned Phase 2 open-label, multicenter study of repeated intrathecal administration of autologous mesenchymal stem cells secreting neurotrophic factors (MSC-NTF) in...
Asterias Expands The Indication Exploration Scope For AST-OPC1 Cell Therapy
Asterias Biotherapeutics, Inc. is a biotechnology company dedicated to developing cell-based therapeutics to treat neurological conditions associated with demyelination and cellular immunotherapies to treat cancer. Asterias is presently focused on advancing three clinical-stage programs which have the potential to...
In-Home Clinical Services Enhanced By LabConnect And Symphony Clinical Research Partnership
LabConnect, LLC, was founded in 2002, providing a global central laboratory, biorepository and client-inspired support services which include routine specialized laboratory testing, kit building, sample management, and data management, serving biopharmaceutical, medical device, and Contract Research Organisation (CRO) clients....
